Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2000

01-12-2001 | Paper Report

Carbonic anhydrase expression in DCIS

Author: Rodolfo Laucirica

Published in: Breast Cancer Research | Issue 1/2000

Login to get access

Excerpt

Hypoxia has been associated with biologically aggressive tumors, possibly through upregulation of hypoxia-inducible genes. The authors recently identified two hypoxia identifiable genes, carbonic anhydrase (CA) CA IX and CA XII, in epithelial tumor cell lines. In this study, the researchers attempted to correlate expression of these genes with benign, preinvasive, and invasive carcinomas of the breast as well as with proliferative activity and mammographically detected calcification. …
Literature
1.
Wykoff CC, Beasley N, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL: Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situof the breast. Am J Pathol . 2001, 158: 1011-1019. CrossRefPubMedPubMedCentral
Metadata
Title
Carbonic anhydrase expression in DCIS
Author
Rodolfo Laucirica
Publication date
01-12-2001
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-2001-68455

Other articles of this Issue 1/2000

Breast Cancer Research 1/2000 Go to the issue

Paper Report

Tissue microarray validation

Research article

Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system

Paper Report

Chromosome 6 alterations

Commentary

Syk: a new player in the field of breast cancer

Paper Report

Breast cell interactions within a 3D model culture system

Paper Report

Vaccination of breast cancer patients with MUC1 keyhole limpet hemocyanin conjugate plus QS-21
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits